← Back to home

HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT

Clinical trials for HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT explained in plain language.

Never miss a new study

Get alerted when new HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT trials appear

Sign up with your email to follow new studies for HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Scientists Re-Analyze old samples to unlock secrets of HER2-Low breast cancer

Knowledge-focused Completed

This study looked at tissue samples from 2751 women with early breast cancer who had already been treated with chemotherapy. The goal was to see if cancers with low levels of HER2 protein (HER2-low) are different from those with no HER2 (HER2-zero). By comparing these groups, res…

Matched conditions: HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT

Sponsor: Hellenic Cooperative Oncology Group • Aim: Knowledge-focused

Last updated May 17, 2026 01:47 UTC

HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT

Get alerted when new HER2 LOW AND HER2 ZERO PATIENTS WITH OPERABLE BREAST CANCER TREATED WITH DDS-CT trials appear

Scientists Re-Analyze old samples to unlock secrets of HER2-Low breast cancer